David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.

Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

Shop till you drop: Could Trump upend, reset the age of the insatiable American consumer?

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

And since GLP-1s come with side effects including fatigue, digestive difficulties, and loss of muscle, products to address ...

While medications like Wegovy promise quick results, many people still prefer a drug-free path to shedding pounds. Science ...

Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Menopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...